Asunto(s)
Adenocarcinoma , Neoplasias del Ano , Fístula Rectal , Humanos , Masculino , Adulto , Neoplasias del Ano/patología , Neoplasias del Ano/genética , Neoplasias del Ano/diagnóstico , Adenocarcinoma/patología , Adenocarcinoma/genética , Adenocarcinoma/metabolismo , Fístula Rectal/patología , Proteínas Proto-Oncogénicas p21(ras)/genética , Mucina 2/metabolismoAsunto(s)
Fístula Rectal , Canal Anal/cirugía , Humanos , Fístula Rectal/cirugía , Resultado del TratamientoRESUMEN
Patients with gastric cancer harbor distinct microbiota in the stomach. It features with lowered biodiversity, discrete structure, and varied composition. Some bacteria from gastric microbiota are potentially carcinogenic as they are enriched or depleted in gastric cancer. Distinct profile of microbial community in gastric cancer is possibly resulted from altered caused by pathophysiological and environmental factors. H. pylori is a carcinogen colonizing the human stomach. Although persisting for decades, it rarely causes compositional alteration of microbiota. Secretion of acid decreases gradually during the carcinogenic process. Increased pH results in overgrowth of bacteria in gastric fluid. The abundance of a particular taxon, but not the profile of microbiota, is altered in proton pump inhibitor users. Compositions of microbiota vary substantially between individuals, which may account for differential cancer risk. It has been demonstrated that genetic variations contribute to inter-individual variations in gut microbiota. However, their influence on the composition of gastric microbiota requires further exploration. Currently, it appears disrupted homeostasis and inter-individual variations of gastric microbiota are involved in cancer development. Clarifying factors responsible for these changes would reveal how microbiota induces carcinogenesis, benefiting the prevention of gastric cancer.
Asunto(s)
Bacterias/crecimiento & desarrollo , Jugo Gástrico/microbiología , Neoplasias Gástricas/microbiología , Estómago/microbiología , Animales , Bacterias/genética , Bacterias/metabolismo , Disbiosis , Ácido Gástrico/metabolismo , Jugo Gástrico/metabolismo , Infecciones por Helicobacter/epidemiología , Infecciones por Helicobacter/microbiología , Helicobacter pylori/crecimiento & desarrollo , Interacciones Huésped-Patógeno , Humanos , Concentración de Iones de Hidrógeno , Factores de Riesgo , Estómago/patología , Neoplasias Gástricas/epidemiología , Neoplasias Gástricas/metabolismo , Neoplasias Gástricas/patologíaRESUMEN
Objective: To investigate degrees of fibrosis of adenomyosis (AM) myometrium and explore its relationship with dysmenorrhea. Methods: Thirty AM patients who had hysterectomy from July, 2015 to December, 2016 in Beijing Obstetrics and Gynecology Hospital were selected as AM group; 28 cases of hysterectomy due to cervical lesions (none AM) were selected as control group. The area ratio of collagen fiber in the two groups was analysed by modified Masson stain, and the expression of collagen type â protein in the two groups was analysed by immunohistochemical method. Results: (1) The degree of fibrosis:the area ratio of collagen fiber and the expression of collagen type â of AM group [(34.5±5.1)%, 0.23±0.06] were significantly higher than those of control group [(26.7±10.1)%,0.18±0.08; all P<0.05]. (2) The relationship between the degree of fibrosis and dysmenorrhea: the area ratio of collagen fiber and the expression of collagen type â in severe dysmenorrhea, moderate dysmenorrhea, and none-mild dysmenorrhea were (35.3±4.3) %, 0.25±0.05; (35.7±3.2) %, 0.26±0.06; (25.0±2.9) %, 0.15±0.03, there were significantly different among them (all P<0.01) . And the area ratio of collagen fiber, the expression of collagen typeâ were positively correlated with the degree of dysmenorrhea (r=0.50, 0.50; all P<0.05) . Conclusions: The area ratio of collagen fiber and the expression of collagen type â in AM are higher than in control group, and positively correlated with the severity of dysmenorrhea. These results suggest the degrees of fibrosis might be correlated with dysmenorrhea.
Asunto(s)
Adenomiosis , Dismenorrea , Endometrio , Femenino , Humanos , Histerectomía , MiometrioRESUMEN
Ulcerative foot infection is a chronic complication frequently seen in diabetic patients, and can result in disability. To evaluate insulin pump treatment for type 2 diabetes in combination with ulcerative foot infection, we selected 168 diabetic patients who developed foot ulcers and received treatment from April 2012 to April 2014 in the Peoples Hospital of Zhengzhou, Henan, China. The patients were divided into a treatment group and a control group, 84 in each group. Besides anti-infection treatment, patients in the control group were given multiple subcutaneous insulin injection (MSII), while patients in the treatment group were given continuous subcutaneous insulin infusion (CSII). Ulcer area, fasting plasma glucose (FPG), C-reactive protein (CRP) and count of white blood cells (WBC) were recorded before treatment, one week after treatment, two weeks after treatment and four weeks after treatment; moreover, ulcer healing condition was recorded four weeks after treatment and the related factors were analyzed. Patients in the treatment group showed an obviously narrowed ulcer area two and four weeks after treatment (P less than 0.05) and significantly lowered levels of FPG, CRP and WBC in the 1st, 2nd and 3rd weeks after treatment (P less than 0.05); four weeks after treatment, 88.1% of patients in the treatment group and 66.7% in the control group had healed well, and the difference between two groups was statistically significant (χ2=5.509, P=0.019). Multi-factor logistic regression analysis indicated that levels of FPG, CRP and WBC at baseline and four weeks after treatment had a positive correlation to ulcer healing (P less than 0.05). All the above findings suggest that insulin pump can improve ulcer healing of patients suffering from diabetic foot ulcers as it effectively controls blood glucose level, restrains inflammatory reaction and prevents spreading of infection.